Cover Image
市場調查報告書

分析工具:肺癌

Lung Cancer: Analytical Tool

出版商 BioSeeker Group AB 商品編碼 207057
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
分析工具:肺癌 Lung Cancer: Analytical Tool
出版日期: 2016年08月22日 內容資訊: 英文
簡介

根據調查,肺癌治療藥物市場預期從2010年至2015年間將超越40億美元的市場規模。化學療法藥物預料將受到學名藥參與的影響,而Aventis的Taxotere(docetaxel)、Bristol-Myers Squibb的Paraplatin(carboplatin)、Eli Lilly的Gemzar(gemcitabine)的主要3個藥物專利將於2012年前失效。

本工具,為「Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market(肺癌:從研究至上市的產品線最適化的決策支援工具)」與「Lung Cancer Drug Pipeline Update 2011(肺癌治療藥物產品線:2011年)」的優質結合產品,並揭示最新肺癌治療藥物開發動向的可搜尋資料庫軟體。概略由下列摘要形式闡述。

肺癌:從研究至上市的產品線最適化的決策支援工具

  • 報告摘要
  • 簡介
  • 最大的治療結果與投資報酬率相關的肺癌治療藥物的治療標的
    • 癌症的藥劑重新定位
    • 肺癌治療藥物標的的簡介
    • 癌症基因計劃與肺癌治療藥物標的
    • 肺癌治療結構基礎的藥物設計受到生物學標的的可獲得結構資料而促進
    • 肺癌治療藥物標的的標的間的相互作用
    • 藥劑與標的與競爭環境
    • 肺癌治療標的蛋白質發現等級
    • 肺癌治療的路徑評價
  • 登錄前至上市:新式以及獨特的藥劑標的策略
    • 第3階段
    • 第2階段
    • 第1階段
    • 前臨床開發
    • 中止・結束的藥劑標的策略
    • 標的策略開發檔案資料
  • 化合物策略
    • 小分子
    • 縮氨酸・蛋白質
    • 抗體
    • 核酸治療
    • 細胞・基因治療
    • 藥物投遞與奈米科技
    • 以藥劑標的的次細胞局部化為基礎的化合物策略
  • 肺癌治療藥物的適應選擇
    • NSCLC
    • SCLC
    • 肺癌
  • 產品線與產品組合計畫

肺癌治療藥物產品線:2011年

  • 臨床實驗責任醫師
  • 藥劑名(異名)
    • 商標名・學名藥名・編碼名
  • 開發階段
    • 開發中的442項藥劑相關的508個開發計畫
      • 上市藥劑
      • 登錄藥劑
      • 登錄前的藥劑
      • 第III階段計畫
      • 第II階段計畫
      • 第I階段計畫
      • 臨床前
      • 無資料
      • 中斷
      • 中止
  • 適應
  • 標的
    • 242項標的相關藥劑以61個分子功能分類
    • 標的以25個局部化分類
  • 標的發現檔案資料
  • 標的訊息路徑
  • 機制
  • 化合物
  • 藥劑檔案資料
    • 藥劑名
    • 臨床實驗擔任醫師以及夥伴
    • 標的以及標的的分子功能
    • 標的部位
    • 標的發現檔案資料
    • 標的訊息路徑
    • 機制
    • 開發計畫
    • 藥劑解說
    • 化合物資料
    • 專利資料
    • 商業與市場
    • 第3階段資料
    • 第2階段資料
    • 第1階段資料
    • 臨床前資料
    • 授權情報
  • 應用特性
    • 13項參數
    • 相關網路資源的應用
    • 情報的提供與分擔
  • 系統必要條件
    • Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
    • Browser Application (Internet Explorer, Firefox, Chrome, Safari)
    • Internet access (to access related internet resources)

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BSG0603141

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals from a business development, drug development or investment perspective.

BioSeeker's Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering:

  • Target Scouting
  • Early & Late Stage Pipeline Analysis
  • Biomarker/Companion Diagnostic Analysis
  • Deal & Alliance Analysis
  • Combination Therapy Analysis
  • Indication Selection & Expansion Analysis
  • First-in-Class Analysis
  • Drug Repositioning
  • Pipeline Analysis by Targeted Pathways

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this desktop app you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf. It covers more than 553 companies plus partners who are today developing 1130 lung cancer drugs where of 809 are active in 884 developmental projects in cancer across 435 different targets. The Analytical Tool and its contents are yours to keep and data can be easily exported into Excel format for mixing with your own proprietary information.

Let our expertise work for you

While executing some of your daily tasks in our Analytical Tools you will benefit from almost two decades of our experience in perfecting features and analysis, allowing you to easily create breakdowns, tables, graphs and exports for your reports, presentations and conference attendance via our easy to use point and click interface.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of BioSeeker's Analytical Tools come with one year of free online access to twice-weekly updates in both contents and features (valued at $2375), pipeline alerts and online support. You can choose to renew your access to these updates and support on a yearly basis or go completely online with our industry leading full service platform, 1stOncology.

Your key to accessing the 1stOncology Newsdesk

As a special bonus, your Analytical Tool unlocks lifetime(*) access to the 1stOncology Newdesk! This service, which is normally reserved for full 1stOncology users only, is a live stream of breaking news within the oncology industry. Updated every 5 minutes, you can tune in to specific channels such as Social Media, Clinical Trials, Intellectual Property, Financial data and Press Releases. This is a great tool to ensure your surveillance of your area of interest is complete.

Did you know?

BioSeeker's Analytical Tools are a longstanding series of products powering decision making in oncology since 1999. Transform your computer's desktop to a dedicated oncology workbench today! Request sample pages or order here to ensure you are not missing out on what you need to know.

System Requirements

  • Operating system: Windows (2000/XP/Vista/7/10) for Desktop App and Mac OSX access only via our online service.
  • Browser Application (Internet Explorer, FireFox, Chrome or Safari))
  • Internet access (to access related internet resources)

(*) In this context, lifetime access refers to the full period of time that BioSeeker Group offer a Newsdesk product or similar news based service.

Back to Top